| Specifications | |
|---|---|
| Product type | mRNA |
| Modified bases | 5-Methyl-CTP |
| 5' Cap | Cap 0 |
| Species | Human |
| RefSeq | NM_001197216.3 |
| Applications | Gene therapy research |
| Format | Powder |
| Quantity | 100 µg |
| Purification | Chromatography |
| Target Gene | |
|---|---|
| Gene ID | 432 |
| UniProt ID | P07306 |
| Specifications | |
|---|---|
| Product type | mRNA |
| Modified bases | 5-Methyl-CTP |
| 5' Cap | Cap 0 |
| Species | Human |
| RefSeq | NM_001197216.3 |
| Applications | Gene therapy research |
| Format | Powder |
| Quantity | 100 µg |
| Purification | Chromatography |
| Target Gene | |
|---|---|
| Gene ID | 432 |
| UniProt ID | P07306 |
| Download |
|---|
| Download resources about mRNA therapeutics development to boost your research. |
| CUSTOMER REVIEWS and Q&As | |
|---|---|
|
There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ASGR1, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) (GTTS-WK24810MR). Click the button above to contact us or submit your feedback about this product. |
|
| See other products | |||
|---|---|---|---|
| CAT | Product Name | Product Type | CDs |
| GTTS-WK22873MR | IVTScrip™ mRNA-Human ARFIP2, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) | mRNA | ARFIP2 |
| GTTS-WK0912MR | IVTScrip™ mRNA-Human CYR61, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) | mRNA | CYR61 |
| GTTS-WK11670MR | IVTScrip™ mRNA-Human ADRBK2, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) | mRNA | ADRBK2 |
| GTTS-WK16767MR | IVTScrip™ mRNA-Human ANXA8L1, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) | mRNA | ANXA8L1 |
| GTTS-WK22133MR | IVTScrip™ mRNA-Human ASXL3, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) | mRNA | ASXL3 |
| GTTS-WK21781MR | IVTScrip™ mRNA-Human ARRDC3-AS1, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) | mRNA | ARRDC3-AS1 |
| GTTS-WK14361MR | IVTScrip™ mRNA-Human ADORA2B, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) | mRNA | ADORA2B |
| GTTS-WK22010MR | IVTScrip™ mRNA-Human ARHGEF16, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) | mRNA | ARHGEF16 |